Toll-like receptor signaling in parasitic infections
- 20 April 2015
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 11 (6) , 771-780
Abstract
The essential role played by Toll-like receptors (TLRs) during parasitic infections, as a part of the innate immune response, has gained much attention. TLR-induced signaling pathways can eradicate invading pathogens. However, uncontrolled activation of TLR leads to tissue damage. Therefore, negative regulation of TLRs results in diminished pro-inflammatory cytokine production and limits excessive pathology. This review outlines the interplay between TLR-mediated responses and some parasitic infections that involve both activation and negative regulation of TLRs. Furthermore, the promising role of TLRs in both therapeutic strategies and vaccine development for parasitic infections will be highlighted. Moreover, treatment of other diseases, for example, inflammatory bowel diseases, using parasite-derived TLR ligands has initiated a new era in immunotherapy.Keywords
This publication has 129 references indexed in Scilit:
- Dissecting negative regulation of Toll-like receptor signalingTrends in Immunology, 2012
- Pathogen-Derived Oligosaccharides Improve Innate Immune Response to Intracellular Parasite InfectionThe American Journal of Pathology, 2011
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- Macroparasites, innate immunity and immunoregulation: developing natural modelsTrends in Parasitology, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Toll-like receptors, wound healing, and carcinogenesisJournal of Molecular Medicine, 2008
- Activation and regulation of Toll-Like Receptors (TLRs) by helminth parasitesImmunologic Research, 2008
- Pathogen Recognition and Innate ImmunityCell, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004
- MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll‐like receptor 2 signalingEuropean Journal of Immunology, 2003